News
Published on: 09. January 2024

Eisai authorized to sell Alzheimer's drug in China

22.2.2023 BESCHREIBUNG: Medical science laboratory. Concept of bacteria research against covid-19 coronavirus, Medical science laboratory. Concept of virus research, Medical science laboratory. Concept of virus research, 22.02.2023, Copyright: xalphaspiritx Panthermedia33672077

Eisai and Biogen have now received approval for their new Alzheimer's drug, Leqembi, in China. Around 10 million people in the People's Republic suffer from the disease. The drug is not yet sold in Europe.

Redaktion Table

Sign up now and continue reading immediately

No credit card details required. No automatic renewal.

Sie haben bereits das Table.Briefing Abonnement?

Anmelden und weiterlesen

Last updated: 24. July 2025

Medizin
Share
Copied!